A detailed history of Symmetry Investments LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Symmetry Investments LP holds 13,400 shares of BMY stock, worth $703,500. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,400
Holding current value
$703,500
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $539,350 - $710,066
13,400 New
13,400 $557,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $995,633 - $1.19 Million
20,537 New
20,537 $1.05 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Symmetry Investments LP Portfolio

Follow Symmetry Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Investments LP with notifications on news.